VYNE Therapeutics Inc. (VYNE) Social Stream



VYNE Therapeutics Inc. (VYNE): $0.32

0.01 (+3.78%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VYNE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

VYNE Therapeutics Inc (VYNE) Price Targets From Analysts

Use the tables below to see what analysts covering VYNE Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-16 6 $14 $3 $6.666 $0.73 813.15%
2021-11-11 6 $14 $3 $6.5 $0.73 790.41%
2021-12-06 5 $14 $3 $7.166 $0.73 881.64%
2022-03-21 6 $14 $3 $7.166 $0.73 881.64%

The Trend in the Analyst Price Target


Over the past 38 weeks, VYNE's average price target has gone down $4.26.

Over the past 50 weeks, VYNE's average upside potential has been 334.43%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 0 40 10 19.430 6.005 223.56%
2021-04-25 0 40 10 19.430 5.180 275.1%
2021-05-08 0 40 10 19.430 3.630 435.26%
2021-09-19 6 10 3 5.000 1.570 218.47%
2022-03-21 6 14 3 7.166 0.700 923.71%

VYNE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 90 days, VYNE's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how VYNE Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 591.5% of that group.
  • To contextualize these metrics, consider that out of all US stocks, VYNE Therapeutics Inc's variance in analysts' estimates is lower than -489.7% of them.
  • In the context of Healthcare stocks, VYNE Therapeutics Inc's average analyst price target is greater than 61.32% of them.
  • In the context of stocks in the small market cap category, VYNE Therapeutics Inc's number of analysts covering the stock is greater than 420.85% of them.

In the Pharmaceutical Products industry, VTYX, VTGN, and VSTM are the three stocks most similar to VYNE Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is VYNE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5587 seconds.